BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17687254)

  • 21. Hemodialysis Arteriovenous Vascular Access Creation After Kidney Transplant Failure.
    Zhang JC; Al-Jaishi A; Perl J; Garg AX; Moist LM
    Am J Kidney Dis; 2015 Oct; 66(4):646-54. PubMed ID: 25975965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fistulae or catheter for elderly who start hemodialysis without permanent vascular access?].
    García Cortés MJ; Viedma G; Sánchez Perales MC; Borrego FJ; Borrego J; Pérez del Barrio P; Gil Cunquero JM; Liébana A; Pérez Bañasco V
    Nefrologia; 2005; 25(3):307-14. PubMed ID: 16053012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic arterial rejection and immunogenicity of the extracellular matrix in iso-, allo- and xenograft in rats].
    Allaire E; Michel JB
    Chirurgie; 1993-1994; 119(10):634-41. PubMed ID: 7729181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
    Koskinen PK; Lemström KB; Häyry PJ
    Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome and complications of permanent hemodialysis vascular access in Nigerians: a single centre experience.
    Alhassan SU; Adamu B; Abdu A; Aji SA
    Ann Afr Med; 2013; 12(2):127-30. PubMed ID: 23713021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryopreservation alters antigenicity of allografts in a porcine model of transplant vasculopathy.
    Solanes N; Rigol M; Castellà M; Khabiri E; Ramírez J; Segalés J; Roqué M; Agustí E; Pérez-Villa F; Roig E; Pomar JL; Sanz G; Heras M
    Transplant Proc; 2004 Dec; 36(10):3288-94. PubMed ID: 15686747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allograft replacement for infrarenal aortic graft infection: early and late results in 179 patients.
    Kieffer E; Gomes D; Chiche L; Fléron MH; Koskas F; Bahnini A
    J Vasc Surg; 2004 May; 39(5):1009-17. PubMed ID: 15111853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients.
    Valeri A; Radhakrishnan J; Ryan R; Powell D
    Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of implementation of an optimized care protocol on the outcome of arteriovenous hemodialysis access surgery.
    Flu H; Breslau PJ; Krol-van Straaten JM; Hamming JF; Lardenoye JW
    J Vasc Surg; 2008 Sep; 48(3):659-68. PubMed ID: 18572358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo behavior of decellularized vein allograft.
    Martin ND; Schaner PJ; Tulenko TN; Shapiro IM; Dimatteo CA; Williams TK; Hager ES; DiMuzio PJ
    J Surg Res; 2005 Nov; 129(1):17-23. PubMed ID: 16139306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective multicenter study with a 1-year analysis of a new vascular graft used for early cannulation in patients undergoing hemodialysis.
    Glickman MH; Burgess J; Cull D; Roy-Chaudhury P; Schanzer H
    J Vasc Surg; 2015 Aug; 62(2):434-41. PubMed ID: 25953016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The end stage of dialysis access: femoral graft or HeRO vascular access device.
    Kudlaty EA; Pan J; Allemang MT; Kendrick DE; Kashyap VS; Wong VL
    Ann Vasc Surg; 2015 Jan; 29(1):90-7. PubMed ID: 24952298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of cryopreserved cadaveric vein allograft for hemodialysis access precludes kidney transplantation because of allosensitization.
    Benedetto B; Lipkowitz G; Madden R; Kurbanov A; Hull D; Miller M; Bow L
    J Vasc Surg; 2001 Jul; 34(1):139-42. PubMed ID: 11436087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimally invasive salvage therapy for transplanted renal allografts.
    Liu XL; Zu QQ; Wang B; Zhou CG; Zhao LB; Xia JG; Gu M; Shi HB; Liu S
    Ren Fail; 2015; 37(9):1470-5. PubMed ID: 26335729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allograft diabetic nephropathy may progress to end-stage renal disease.
    Salifu MO; Nicastri AD; Markell MS; Ghali H; Sommer BG; Friedman EA
    Pediatr Transplant; 2004 Aug; 8(4):351-6. PubMed ID: 15265161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts.
    Roy-Chaudhury P; Kelly BS; Miller MA; Reaves A; Armstrong J; Nanayakkara N; Heffelfinger SC
    Kidney Int; 2001 Jun; 59(6):2325-34. PubMed ID: 11380837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of immersion formaldehyde fixation on human placental weight.
    Fox GE; Van Wesep R; Resau JH; Sun CC
    Arch Pathol Lab Med; 1991 Jul; 115(7):726-8. PubMed ID: 2064535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of preoperative vascular imaging in the selection and success of hemodialysis access.
    Karakayali F; Ekici Y; Görür SK; Arat Z; Boyvat F; Karakayali H; Haberal M
    Ann Vasc Surg; 2007 Jul; 21(4):481-9. PubMed ID: 17379478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryopreserved small-diameter arterial allografts for arterial by-pass procedures: an experimental study.
    Nataf P; Guettier C; Martinelli L; Regan M; Pavie A; Cabrol C; Gandjbakhch I
    J Cardiovasc Surg (Torino); 1995 Feb; 36(1):79-85. PubMed ID: 7721930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study.
    Conte MS; Nugent HM; Gaccione P; Guleria I; Roy-Chaudhury P; Lawson JH
    J Vasc Surg; 2009 Dec; 50(6):1359-68.e1. PubMed ID: 19958986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.